Vickers MM - Search Results

1

PROSPECT Eligibility and Clinical Outcomes: Results From the Pan-Canadian Rectal Cancer Consortium.

Bossé D, Mercer J, Raissouni S, Dennis K, Goodwin R, Jiang D, Powell E, Kumar A, Lee-Ying R, Price-Hiller J, Heng DY, Tang PA, MacLean A, Cheung WY, Vickers MM. Bossé D, et al. Among authors: vickers mm. Clin Colorectal Cancer. 2016 Sep;15(3):243-9. doi: 10.1016/j.clcc.2016.02.003. Epub 2016 Feb 13. Clin Colorectal Cancer. 2016. PMID: 26964803

2

Tolerance of sunitinib in dialyzed patients with metastatic renal cell carcinoma.

Vickers MM, Heng DY, Hemmelgarn B, Eigl BJ. Vickers MM, et al. Clin Genitourin Cancer. 2009 Oct;7(3):E104-6. doi: 10.3816/CGC.2009.n.035. Clin Genitourin Cancer. 2009. PMID: 19815480

3

Clinical outcome in metastatic renal cell carcinoma patients after failure of initial vascular endothelial growth factor-targeted therapy.

Vickers MM, Choueiri TK, Rogers M, Percy A, Finch D, Zama I, Cheng T, North S, Knox JJ, Kollmannsberger C, McDermott DF, Rini BI, Heng DY. Vickers MM, et al. Urology. 2010 Aug;76(2):430-4. doi: 10.1016/j.urology.2009.12.031. Epub 2010 Mar 12. Urology. 2010. PMID: 20223508

4

Prognostic and predictive biomarkers in renal cell carcinoma.

Vickers MM, Heng DY. Vickers MM, et al. Target Oncol. 2010 Jun;5(2):85-94. doi: 10.1007/s11523-010-0143-8. Epub 2010 Jun 28. Target Oncol. 2010. PMID: 20582732 Review.

5

Characterization of published errors in high-impact oncology journals.

Molckovsky A, Vickers MM, Tang PA. Molckovsky A, et al. Among authors: vickers mm. Curr Oncol. 2011 Jan;18(1):26-32. doi: 10.3747/co.v18i1.707. Curr Oncol. 2011. PMID: 21331279 Free PMC article.

6

Clinical and molecular prognostic factors in renal cell carcinoma: what we know so far.

Tang PA, Vickers MM, Heng DY. Tang PA, et al. Among authors: vickers mm. Hematol Oncol Clin North Am. 2011 Aug;25(4):871-91. doi: 10.1016/j.hoc.2011.04.003. Hematol Oncol Clin North Am. 2011. PMID: 21763972 Review.

7

Comorbidity, age and overall survival in patients with advanced pancreatic cancer - results from NCIC CTG PA.3: a phase III trial of gemcitabine plus erlotinib or placebo.

Vickers MM, Powell ED, Asmis TR, Jonker DJ, Hilton JF, O'Callaghan CJ, Tu D, Parulekar W, Moore MJ. Vickers MM, et al. Eur J Cancer. 2012 Jul;48(10):1434-42. doi: 10.1016/j.ejca.2011.10.035. Epub 2011 Nov 24. Eur J Cancer. 2012. PMID: 22119354 Clinical Trial.

8

Continuity clinics in oncology training programs in Canada.

Croke JM, Vickers MM, E C, Heng DY, Reaume MN, Song X, Meng J, Asmis T, Lochrin C. Croke JM, et al. Among authors: vickers mm. Curr Oncol. 2012 Oct;19(5):e329-42. doi: 10.3747/co.19.1046. Curr Oncol. 2012. PMID: 23144581 Free PMC article.

9

Prognostic factors of survival for patients with metastatic renal cell carcinoma with brain metastases treated with targeted therapy: results from the international metastatic renal cell carcinoma database consortium.

Vickers MM, Al-Harbi H, Choueiri TK, Kollmannsberger C, North S, MacKenzie M, Knox JJ, Rini BI, Heng DY. Vickers MM, et al. Clin Genitourin Cancer. 2013 Sep;11(3):311-5. doi: 10.1016/j.clgc.2013.04.012. Epub 2013 May 15. Clin Genitourin Cancer. 2013. PMID: 23684422

10

One compared with two cycles of mitomycin C in chemoradiotherapy for anal cancer: analysis of outcomes and toxicity.

Yeung R, McConnell Y, Roxin G, Banerjee R, Urgoiti GB, MacLean AR, Buie WD, Mulder KE, Vickers MM, Joseph KJ, Doll CM. Yeung R, et al. Among authors: vickers mm. Curr Oncol. 2014 Jun;21(3):e449-56. doi: 10.3747/co.21.1903. Curr Oncol. 2014. PMID: 24940105 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

59 results

Search Page

Filters